US6262096B1
(en)
|
1997-11-12 |
2001-07-17 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
JP2002518380A
(ja)
*
|
1998-06-18 |
2002-06-25 |
ブリストル−マイヤーズ スクイブ カンパニー |
サイクリン依存キナーゼの炭素置換アミノチアゾール抑制剤
|
US6407124B1
(en)
|
1998-06-18 |
2002-06-18 |
Bristol-Myers Squibb Company |
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
|
US6414156B2
(en)
|
1998-10-21 |
2002-07-02 |
Bristol-Myers Squibb Company |
Process for preparing azacycloalkanoylaminothiazoles
|
US6214852B1
(en)
|
1998-10-21 |
2001-04-10 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
US6610846B1
(en)
|
1999-03-29 |
2003-08-26 |
Hoffman-La Roche Inc. |
Heteroaromatic glucokinase activators
|
US6320050B1
(en)
|
1999-03-29 |
2001-11-20 |
Hoffmann-La Roche Inc. |
Heteroaromatic glucokinase activators
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
BR0009721A
(pt)
|
1999-04-15 |
2002-02-13 |
Bristol Myers Squibb Co |
Inibidores de tirosina quinase de proteìna cìclica
|
AR030154A1
(es)
*
|
1999-07-05 |
2003-08-13 |
Nihon Nohyaku Co Ltd |
Derivado de ftalamida, derivado de amina heterociclico util como intermediario para la produccion del mismo, insecticida agrohorticola y metodo para utilizar dicho insecticida
|
US6114365A
(en)
*
|
1999-08-12 |
2000-09-05 |
Pharmacia & Upjohn S.P.A. |
Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
|
US6392053B2
(en)
|
1999-12-15 |
2002-05-21 |
Bristol-Myers Squibb Company |
Process for preparing arylacetylaminothiazoles
|
US6515004B1
(en)
|
1999-12-15 |
2003-02-04 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
IT1317826B1
(it)
|
2000-02-11 |
2003-07-15 |
Dompe Spa |
Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
|
DE10037310A1
(de)
*
|
2000-07-28 |
2002-02-07 |
Asta Medica Ag |
Neue Indolderivate und deren Verwendung als Arzneimittel
|
DE60127420T2
(de)
|
2000-08-17 |
2007-11-29 |
Lumera Corp., Bothell |
Design und synthese von nlo-materialien für electro-optische anwendungen, die von thiophen abgeleitet sind
|
NZ525892A
(en)
*
|
2000-11-27 |
2004-11-26 |
Pharmacia Italia S |
Phenylacetamido- pyrazole derivatives their use as antitumor agents and preparation process thereof
|
DE60117605T2
(de)
|
2000-12-21 |
2006-12-07 |
Bristol-Myers Squibb Co. |
Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
|
US6756374B2
(en)
|
2001-01-22 |
2004-06-29 |
Hoffmann-La Roche Inc. |
Diaminothiazoles having antiproliferative activity
|
EP1256578B1
(en)
*
|
2001-05-11 |
2006-01-11 |
Pfizer Products Inc. |
Thiazole derivatives and their use as cdk inhibitors
|
SE0102299D0
(sv)
|
2001-06-26 |
2001-06-26 |
Astrazeneca Ab |
Compounds
|
HN2002000156A
(es)
|
2001-07-06 |
2003-11-27 |
Inc Agouron Pharmaceuticals |
Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
|
EP1724270A3
(en)
|
2001-07-19 |
2007-01-03 |
Pfizer Italia S.r.l. |
Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
|
EA007392B1
(ru)
*
|
2001-07-19 |
2006-10-27 |
Фармация Италия С.П.А. |
Фенилацетамидотиазольные производные, способ их получения и их использования в качестве противоопухолевых средств
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
CA2460347A1
(en)
*
|
2001-09-13 |
2003-03-20 |
Synta Pharmaceuticals Corp. |
3-glyoxlylamideindoles for treating cancer
|
CA2469228A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Azole compound and medicinal use thereof
|
JP4419571B2
(ja)
|
2002-03-26 |
2010-02-24 |
萬有製薬株式会社 |
新規アミノベンズアミド誘導体
|
CN100357283C
(zh)
*
|
2002-04-02 |
2007-12-26 |
中国科学院上海药物研究所 |
一类甲硫氨酰氨肽酶抑制剂
|
SE0201194D0
(sv)
*
|
2002-04-19 |
2002-04-19 |
Astrazeneca Ab |
New compounds
|
JP4091600B2
(ja)
|
2002-04-26 |
2008-05-28 |
エフ.ホフマン−ラ ロシュ アーゲー |
置換フェニルアセトアミド及びグルコキナーゼ活性化物質としてのその使用
|
AU2003249534A1
(en)
*
|
2002-08-13 |
2004-02-25 |
Warner-Lambert Company Llc |
6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors
|
WO2004050645A1
(en)
*
|
2002-10-03 |
2004-06-17 |
Novartis Ag |
Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
|
AU2003288956A1
(en)
*
|
2002-10-30 |
2004-06-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of rock and other protein kinases
|
GB0226931D0
(en)
*
|
2002-11-19 |
2002-12-24 |
Astrazeneca Ab |
Chemical compounds
|
MY141521A
(en)
|
2002-12-12 |
2010-05-14 |
Hoffmann La Roche |
5-substituted-six-membered heteroaromatic glucokinase activators
|
FR2850380B1
(fr)
*
|
2003-01-23 |
2006-07-07 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur utilisation en therapeutique
|
CA2519899A1
(en)
*
|
2003-03-27 |
2004-10-14 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
ES2378620T3
(es)
*
|
2003-03-27 |
2012-04-16 |
Cytokinetics, Inc. |
Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
|
JP2007504255A
(ja)
*
|
2003-09-06 |
2007-03-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atp結合カセットトランスポーターの調節因子
|
AR046276A1
(es)
*
|
2003-10-07 |
2005-11-30 |
Renovis Inc |
Derivados de amida como ligandos de canales ionicos y composiciones farmaceuticas y metodos que los utilizan.
|
TW200524887A
(en)
*
|
2003-10-27 |
2005-08-01 |
Lundbeck & Co As H |
N-thiazol-2-yl-benzamide derivatives
|
ZA200605624B
(en)
*
|
2004-01-12 |
2007-11-28 |
Applied Research Systems |
Thiazole derivatives and use thereof
|
EP1555264A1
(en)
*
|
2004-01-15 |
2005-07-20 |
Sireen AG |
Five-membered heterocyclic compounds as inhibitors of SRC family protein kinase.
|
JP4960708B2
(ja)
*
|
2004-01-30 |
2012-06-27 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atp結合カセットトランスポーターのモジュレーター
|
US7977322B2
(en)
|
2004-08-20 |
2011-07-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-binding cassette transporters
|
US7582770B2
(en)
|
2004-02-20 |
2009-09-01 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US7384968B2
(en)
*
|
2004-04-01 |
2008-06-10 |
Pfizer Inc. |
Thiazole-amine compounds for the treatment of neurodegenerative disorders
|
FR2868421B1
(fr)
*
|
2004-04-01 |
2008-08-01 |
Aventis Pharma Sa |
Nouveaux benzothiazoles et leur utilisation comme medicaments
|
US7211576B2
(en)
|
2004-04-20 |
2007-05-01 |
Hoffmann-La Roche Inc. |
Diaminothiazoles
|
UA90864C2
(en)
*
|
2004-09-09 |
2010-06-10 |
Ромарк Лебораториз, Л.К. |
Halogenated benzamide derivatives
|
EA200700707A1
(ru)
|
2004-09-22 |
2007-08-31 |
Х. Лундбекк А/С |
Производные 2-ациламинотиазола
|
EP1804786A4
(en)
*
|
2004-09-29 |
2008-01-02 |
Cytovia Inc |
SUBSTITUTED N-ARYL-9-OXO-9H-FLUORENE-1-CARBOXAMIDES AND ANALOGUES AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS
|
US20080171788A1
(en)
*
|
2005-02-08 |
2008-07-17 |
Shinobu Akuzawa |
Medicament For Irritable Bowel Syndrome
|
BRPI0607583A2
(pt)
*
|
2005-03-04 |
2009-09-15 |
Hoffmann La Roche |
derivados de piridin-2-carboxamida como antagonistas mglur5, método para sua preparação, medicamento contendo os mesmos, bem como uso relacionado aos referidos compostos
|
TW200720264A
(en)
*
|
2005-04-25 |
2007-06-01 |
Lundbeck & Co As H |
Pro-drugs of n-thiazol-2-yl-benzamide derivatives
|
US7674912B2
(en)
|
2005-04-25 |
2010-03-09 |
H. Lundbeck A/S |
Pro-drugs of N-thiazol-2-yl-benzamide derivatives
|
JP2008545663A
(ja)
*
|
2005-05-27 |
2008-12-18 |
クイーンズ ユニバーシティ アット キングストン |
タンパク質フォールディング障害の治療
|
EP1907387A1
(en)
|
2005-07-11 |
2008-04-09 |
Mitsubishi Tanabe Pharma Corporation |
An oxime derivative and preparations thereof
|
ZA200805227B
(en)
*
|
2005-12-12 |
2009-11-25 |
Genelabs Tech Inc |
N-(5-memebered heteroarmatic ring)-amido anti-viral compounds
|
MX2008008152A
(es)
*
|
2005-12-23 |
2008-09-12 |
Ariad Pharma Inc |
Compuestos heterociclicos biciclicos.
|
EP1849785A1
(en)
*
|
2006-04-28 |
2007-10-31 |
Neuropharma, S.A. |
N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
|
BRPI0710328A2
(pt)
*
|
2006-05-08 |
2011-08-09 |
Ariad Pharma Inc |
composto da fórmula i, um tautomer da mesma, ou um sal farmaceuticamente aceitável, hidrato ou outro solvato do mesmo e método para o tratamento de cáncer em um mamìfero necessitado do mesmo e composição
|
KR101441365B1
(ko)
|
2006-05-08 |
2014-09-18 |
어리어드 파마슈티칼스, 인코포레이티드 |
모노시클릭 헤테로아릴 화합물
|
WO2008002594A2
(en)
*
|
2006-06-27 |
2008-01-03 |
Neuroprotection For Life Corp. |
Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
|
WO2008084873A1
(ja)
*
|
2007-01-10 |
2008-07-17 |
Mitsubishi Tanabe Pharma Corporation |
オキシム誘導体
|
WO2008084872A1
(ja)
*
|
2007-01-10 |
2008-07-17 |
Mitsubishi Tanabe Pharma Corporation |
ヒドラゾン誘導体
|
WO2008151184A1
(en)
*
|
2007-06-03 |
2008-12-11 |
Vanderbilt University |
Benzamide mglur5 positive allosteric modulators and methods of making and using same
|
US8853392B2
(en)
|
2007-06-03 |
2014-10-07 |
Vanderbilt University |
Benzamide mGluR5 positive allosteric modulators and methods of making and using same
|
KR20100027243A
(ko)
*
|
2007-07-31 |
2010-03-10 |
시오노기세이야쿠가부시키가이샤 |
트롬보포이에틴 수용체 아고니스트 작용을 갖는 광학 활성인 화합물을 함유하는 의약 조성물 및 그 중간체
|
EP2020232A1
(en)
*
|
2007-08-03 |
2009-02-04 |
Zeltia, S.A. |
N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
|
CA2695517C
(en)
*
|
2007-08-03 |
2016-09-20 |
J. Edward Semple |
Alkylsulfonyl-substituted thiazolide compounds
|
ES2322121B1
(es)
*
|
2007-12-10 |
2010-04-19 |
Consejo Superior De Investigaciones Cientificas |
Nuevos derivados de aminoacidos dicarboxilicos y su aplicacion en el tratamiento de enfermedades neurodegenerativas.
|
WO2009106203A1
(en)
*
|
2008-02-25 |
2009-09-03 |
Merck Patent Gmbh |
Glucokinase activators
|
US10793515B2
(en)
|
2008-03-19 |
2020-10-06 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
AU2009225647C1
(en)
*
|
2008-03-19 |
2015-11-19 |
Aurimmed Pharma, Inc. |
Novel compounds advantageous in the treatment of central nervous system diseases and disorders
|
EP2282995B1
(en)
|
2008-05-23 |
2015-08-26 |
Novartis AG |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
NZ602099A
(en)
*
|
2008-07-10 |
2014-06-27 |
Pharma Ip General Inc Ass |
Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
|
EP2365809B8
(en)
|
2008-11-12 |
2018-10-10 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
WO2010107736A2
(en)
*
|
2009-03-20 |
2010-09-23 |
University Of Virginia Patent Foundation |
Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
|
CN105853415A
(zh)
|
2009-05-12 |
2016-08-17 |
罗马克实验室有限公司 |
卤代烷基杂芳基苯甲酰胺化合物
|
EP2440556A1
(en)
*
|
2009-06-10 |
2012-04-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of phosphatidylinositol 3-kinase
|
JP5932640B2
(ja)
|
2009-06-26 |
2016-06-08 |
ロマーク ラボラトリーズ エル.シー. |
インフルエンザを治療するための化合物および方法
|
WO2011076734A1
(en)
*
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
|
WO2011076732A1
(en)
*
|
2009-12-21 |
2011-06-30 |
Euroscreen S.A. |
Compounds, pharmaceutical composition and methods for use in treating gastrointestinal disorders
|
MX367469B
(es)
*
|
2010-06-07 |
2019-08-23 |
Novomedix Llc |
Compuestos furanilo y su uso.
|
EP2594555B1
(en)
*
|
2010-07-02 |
2018-03-07 |
ASKA Pharmaceutical Co., Ltd. |
HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR
|
KR101688978B1
(ko)
*
|
2010-08-18 |
2016-12-26 |
중앙대학교 산학협력단 |
신규한 2-아미노 티아졸 유도체 및 이를 포함하는 항암용 조성물
|
WO2012040170A2
(en)
|
2010-09-20 |
2012-03-29 |
University Of Virginia Patent Foundation |
Compositions and methods for treating tuberculosis
|
WO2012061190A1
(en)
*
|
2010-11-01 |
2012-05-10 |
Romark Laboratories L.C. |
Alkylsulfinyl-substituted thiazolide compounds
|
EP2651930B1
(en)
*
|
2010-12-16 |
2015-10-28 |
Boehringer Ingelheim International GmbH |
Biarylamide inhibitors of leukotriene production
|
US20120225846A1
(en)
*
|
2011-03-02 |
2012-09-06 |
Bioenergenix |
Heterocyclic compounds for the inhibition of pask
|
PT2797416T
(pt)
*
|
2011-12-28 |
2017-10-23 |
Global Blood Therapeutics Inc |
Compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
TWI628170B
(zh)
*
|
2013-02-05 |
2018-07-01 |
先正達合夥公司 |
植物生長調節化合物
|
DE102013204097A1
(de)
*
|
2013-03-11 |
2014-10-30 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Alkylamidothiazolen und einer oder mehreren kosmetisch oder dermatologisch unbedenklichen UV-Filtersubstanzen
|
DE102013204088A1
(de)
*
|
2013-03-11 |
2014-09-11 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch relevanten Duftstoffen
|
DE102013204081A1
(de)
*
|
2013-03-11 |
2014-09-11 |
Beiersdorf Ag |
Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln
|
CN105073728A
(zh)
|
2013-03-15 |
2015-11-18 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
AP2015008718A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
CA2903572A1
(en)
*
|
2013-03-15 |
2014-10-23 |
Epizyme, Inc. |
Substituted benzene compounds
|
US9243001B2
(en)
|
2013-03-15 |
2016-01-26 |
Epizyme, Inc. |
Substituted benzene compounds
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
MY180206A
(en)
|
2013-03-15 |
2020-11-25 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
EA201992707A1
(ru)
|
2013-11-18 |
2020-06-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
EP2878339A1
(en)
|
2013-12-02 |
2015-06-03 |
Siena Biotech S.p.A. |
SIP3 antagonists
|
DK3102208T3
(da)
|
2014-02-07 |
2021-03-08 |
Global Blood Therapeutics Inc |
Krystallinsk polymorf af den frie base af 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyd
|
CN105017174B
(zh)
*
|
2015-07-13 |
2017-03-15 |
南华大学 |
N‑(4‑烷基‑5‑苄基噻唑‑2‑基)烯酰胺及其制备方法与应用
|
CN106467499A
(zh)
*
|
2015-08-18 |
2017-03-01 |
湖南大学 |
N-(4-烷基-5-苄基噻唑-2-基)苯烷酰胺及其作为抗癌药的应用
|
CN105254585A
(zh)
*
|
2015-11-18 |
2016-01-20 |
泰山医学院 |
噻唑酰胺类化合物及其制备方法和应用
|
MA43373A
(fr)
|
2015-12-04 |
2018-10-10 |
Global Blood Therapeutics Inc |
Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
|
AR108435A1
(es)
|
2016-05-12 |
2018-08-22 |
Global Blood Therapeutics Inc |
Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
|
CN107365280B
(zh)
*
|
2016-05-13 |
2020-11-06 |
湖南大学 |
N-(噻唑-2-基)哌嗪基酰胺衍生物及其作为抗癌药物的应用
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
BR112018076812A2
(pt)
*
|
2016-06-21 |
2021-09-28 |
The University Of Melbourne |
Ativadores da latência de hiv
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
US20180289676A1
(en)
*
|
2017-03-30 |
2018-10-11 |
Saint Louis University |
Compounds and methods targeting gper in cancer
|
AU2018285831A1
(en)
*
|
2017-06-14 |
2019-12-19 |
European Molecular Biology Laboratory |
Bicyclic heteroaromatic amide compounds for use in therapy
|
WO2019241376A1
(en)
*
|
2018-06-14 |
2019-12-19 |
The Trustees Of Columbia University In The City Of New York |
Treatment of cognitive disorders using nitazoxanide (ntz), nitazoxanide (ntz) analogs, and metabolites thereof
|
WO2020072377A1
(en)
|
2018-10-01 |
2020-04-09 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
WO2020086625A1
(en)
*
|
2018-10-22 |
2020-04-30 |
The Regents Of The University Of California |
Vaccine adjuvant
|
KR102547762B1
(ko)
*
|
2019-10-04 |
2023-06-26 |
파렌키마바이오텍 주식회사 |
신규 화합물 및 이의 자가면역질환 치료 용도
|
WO2021066573A1
(ko)
*
|
2019-10-04 |
2021-04-08 |
파렌키마바이오텍 주식회사 |
신규 화합물 및 이의 자가면역질환 치료 용도
|
EP3827816A1
(en)
|
2019-11-28 |
2021-06-02 |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz |
Prooxidative chain-transfer agents for use in the treatment of malignant tumour or infectious diseases
|
CN111533735A
(zh)
*
|
2020-05-08 |
2020-08-14 |
张建蒙 |
氧代二氢哒嗪噻唑类衍生物及其在抗肿瘤药物中的应用
|
JP2023545588A
(ja)
*
|
2020-10-16 |
2023-10-30 |
ツェーエムエム-フォルシュングスツェントルム フュア モレクラレ メディツィン ゲーエムベーハー |
ヘテロ環式カリンringユビキチンリガーゼ化合物及びその使用
|
WO2023275796A1
(en)
*
|
2021-07-01 |
2023-01-05 |
Novartis Ag |
Heterocyclic derivatives as sphingosine-1-phosphate 3 inhibitors
|
WO2023131690A1
(en)
*
|
2022-01-10 |
2023-07-13 |
Merck Patent Gmbh |
Substituted heterocycles as hset inhibitors
|
WO2023203172A1
(en)
*
|
2022-04-20 |
2023-10-26 |
Proxygen Gmbh |
Heterocyclic cullin ring ubiquitin ligase compounds and uses thereof
|
CN114874155B
(zh)
*
|
2022-05-10 |
2024-02-06 |
华南理工大学 |
一类苄基噻唑胺类化合物及其制备方法与抗肿瘤应用
|
CN117229275A
(zh)
*
|
2023-08-15 |
2023-12-15 |
北京中医药大学 |
一种新型2-乙酰氨基噻唑化合物及其制备方法与应用
|